Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)
NCT00305487
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
660
Enrollment
INDUSTRY
Sponsor class
Conditions
Hay Fever
Seasonal Allergic Rhinitis
Interventions
DRUG:
Ciclesonide nasal spray
Sponsor
AstraZeneca